1. Home
  2. PVL vs BDSX Comparison

PVL vs BDSX Comparison

Compare PVL & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Permianville Royalty Trust Trust Units

PVL

Permianville Royalty Trust Trust Units

HOLD

Current Price

$1.89

Market Cap

57.8M

Sector

Energy

ML Signal

HOLD

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$7.79

Market Cap

53.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PVL
BDSX
Founded
2011
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Precision Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
57.8M
53.0M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
PVL
BDSX
Price
$1.89
$7.79
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$32.50
AVG Volume (30 Days)
80.3K
55.0K
Earning Date
01-01-0001
11-03-2025
Dividend Yield
19.25%
N/A
EPS Growth
N/A
N/A
EPS
0.06
N/A
Revenue
$3,511,891.00
$80,173,000.00
Revenue This Year
N/A
$20.75
Revenue Next Year
N/A
$25.05
P/E Ratio
$29.20
N/A
Revenue Growth
11.77
22.29
52 Week Low
$1.30
$3.44
52 Week High
$2.04
$32.20

Technical Indicators

Market Signals
Indicator
PVL
BDSX
Relative Strength Index (RSI) 60.52 52.38
Support Level $1.82 $7.68
Resistance Level $1.83 $8.69
Average True Range (ATR) 0.06 0.67
MACD 0.01 0.00
Stochastic Oscillator 86.67 58.95

Price Performance

Historical Comparison
PVL
BDSX

About PVL Permianville Royalty Trust Trust Units

Permianville Royalty Trust is a statutory trust which holds net profits interests in the profits from the sale of oil and natural gas production from non-operated assets of both conventional properties in the States of Texas, Louisiana, and New Mexico as well as unconventional assets in the Permian and Haynesville basins.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Share on Social Networks: